Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android. Learn more here!

Dyskeratosis congenita is a genodermatosis characterized by hyperpigmentation of the skin, dystrophy of the nails, leukoplakia of mucous membranes, and progressive pancytopenia.

Zinsser-Cole-Engman Syndrome; Dyskeratosis Congenita Scoggins type.

Unknown, but approximately 200 cases have been described.

X-linked recessive disorder that affects almost exclusively males (male-to-female ratio = 10:1). However, there are rare case reports of autosomal recessive and autosomal dominant inheritance. The mutant gene has been mapped to Xq28 and encodes for a 514-amino-acid protein called dyskerin.

Dyskerin seems to have a major role in the regulation of cell proliferation (biogenesis of ribosomes and pseudouridylation of recombinant RNA messengers) and therefore primarily affects rapidly proliferating tissues (e.g., skin, gastrointestinal mucosa, and bone marrow).

The phenotype is highly variable; however, bone marrow failure and the triad of reticulated hypopigmentation and hyperpigmentation of the skin, nail dystrophy, and mucocutaneous leukoplakia is typical for dyskeratosis congenita. The onset of skin and nail changes usually is around age 10 years and precedes epiphora and mucocutaneous changes. Although signs of bone marrow failure and malignancy begin to develop in the early to mid-teens, manifestation before age 10 years is not uncommon.

Changes in skin pigmentation (reticulated hypopigmentation and hyperpigmentation) often in combination with telangiectases are more pronounced on the flexures of the big joints, neck, and axillae, and along the inner thigh. Nail dystrophy is progressive and initially may result in longitudinal ridges and finally in complete loss of nails. The hair may be affected, leading to baldness. Leukoplakia most often occurs in the mouth but also may affect other mucosal sites (e.g., esophagus, vagina, anus, urethral meatus, and lacrimal duct resulting in strictures with dysphagia, dyspareunia, dysuria, and epiphora) and is associated with an increased risk for malignancies (most often squamous cell carcinoma). In male patients, testes often are undescended and hypoplastic. Dental abnormalities (extensive cavities, premature loss) and increased fragility of the bones caused by abnormal metaphyseal trabeculation and osteoporosis have been reported. Lacrimal duct stenosis or atresia is present in up to 80% of patients and leads to continuous epiphora. Up to 90% of patients suffer from bone marrow failure; rarely the diagnosis of aplastic anemia precedes the diagnosis of dyskeratosis congenita. Some patients develop myelodysplasia and acute myeloid leukemia. Pancytopenia or complications related to bone marrow transplant (high rate of pulmonary complications) are responsible for approximately 70% of the premature deaths in this population. Approximately 20% of these patients show pulmonary changes with progressive pulmonary fibrosis and restrictive lung disease, arteriovenous shunting with microvascular changes, and reduced diffusion capacity. It has been hypothesized that these underlying changes are, at least in part, responsible for the high rate of pulmonary complications in association with bone marrow transplant. Liver cirrhosis with a nutmeg aspect may be present, and mucosal ulcerations may cause gastrointestinal hemorrhage. Elevated immunoglobulin levels and increased risk of opportunistic infections have been reported. Additional findings (each in approximately 15-20% ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.